Anbenitamab (KN026) is an anti-HER2 bispecific antibody independently developed by Alphamab Oncology using the proprietary Fc-based heterodimer bispecific platform technology called CRIB (Charge ...
With a 96.45% RTP and high volatility, Huntress Wild Vengeance provides a perfect balance of excitement and value. The slot’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback